Interventional Systems’ 2023 Wrap-Up
Let’s wrap up 2023 by looking back at some of the milestones that shaped the year!
Let’s wrap up 2023 by looking back at some of the milestones that shaped the year!
See how Micromate™’s ability to reach challenging anatomical regions has been helping clinical teams perform successful percutaneous procedures from head to toe.
Micromate™ Case Report series presents real cases performed by the physicians currently using our full-fledged robotic platform for percutaneous procedures. For this case report, we
Micromate™ is now the first needle-based intervention robot available for sale in the United States that is compatible with both fluoroscopy and computed tomography (CT).
It’s been a year since we first announced the planning and navigation station of Micromate, and we are celebrating by sharing some of our first CT-guided cases.
Austria-based Interventional Systems has decided to spin-off its validated technology for interventional radiology and oncology into the endourology space.
The ultimate goal of any local treatment in liver cancer, especially for small ones, is the complete tumor eradication to increase patient survival, reduce complications,
Learn more about the recent changes in our company.
Learn how the stable instrument guidance capability of Micromate™ helped the clinical team at St. Antonius Ziekenhuis hospital, the Netherlands, perform a successful robotic-assisted parasternal biopsy.
Learn how a robotic assistance system like Micromate™ can help you improve your IR/IO percutaneous needle interventions.
The 2022 Year in Review is here: let’s take some time to look back on some of our proudest achievements of the year.
See how Micromate™ helped the clinical team at St. Antonius, the Netherlands, perform a successful robotic-assisted lung biopsy.
All rights are reserved by iSYS Medizintechnik GmbH